Coppelli Alberto, Giannarelli Rosa, Mariotti Rita, Rondinini Lorenzo, Fossati Nicoletta, Vistoli Fabio, Aragona Michele, Rizzo Gaetano, Boggi Ugo, Mosca Franco, Del Prato Stefano, Marchetti Piero
Department of Endocrinology and Metabolism, Metabolic Unit, Cisanello Hospital-Pisa University, Pisa, Italy.
Transplantation. 2003 Sep 27;76(6):974-6. doi: 10.1097/01.TP.0000084202.18999.1D.
The effects of pancreas transplant alone (PTA) on cardiovascular risk factors (CRF) and cardiac function in type 1 diabetes mellitus (T1DM) patients are still unsettled.
We studied 13 T1DM patients who received PTA with portal drainage and 11 matched control patients. Parameters of glucose and lipid metabolism and several additional classic CRF were assessed before and up to 6 months posttransplant. Cardiac morphology and function were assessed by Doppler echocardiographic examination.
Insulin independence was promptly achieved and then maintained after PTA. Total and low-density lipoprotein cholesterol levels were significantly lower after transplantation, whereas high-density lipoprotein cholesterol and triglyceride concentrations did not change. Both systolic and diastolic blood pressure values and fibrinogen levels improved significantly. In addition, PTA determined a significant amelioration of several morphologic and functional cardiac indices. None of the measured parameters changed in the control patients.
PTA with portal drainage induces an early improvement of CRF and ameliorates cardiac function in patients with T1DM.
单纯胰腺移植(PTA)对1型糖尿病(T1DM)患者心血管危险因素(CRF)和心脏功能的影响仍未明确。
我们研究了13例接受门静脉引流的PTA的T1DM患者和11例匹配的对照患者。在移植前及移植后6个月内评估血糖和脂质代谢参数以及其他几个经典的CRF。通过多普勒超声心动图检查评估心脏形态和功能。
PTA后迅速实现并维持了胰岛素独立。移植后总胆固醇和低密度脂蛋白胆固醇水平显著降低,而高密度脂蛋白胆固醇和甘油三酯浓度未发生变化。收缩压和舒张压值以及纤维蛋白原水平均显著改善。此外,PTA使几个心脏形态和功能指标得到显著改善。对照患者的所有测量参数均未改变。
门静脉引流的PTA可使T1DM患者的CRF早期改善并改善心脏功能。